| Particulars (Rupees in Crores.) | Sept-2025 | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 |
|---|---|---|---|---|---|
Gross Sales | 1,520 | 1,464 | 1,548 | 1,401 | 1,397 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,520 | 1,464 | 1,548 | 1,401 | 1,397 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 41 | 23 | 39 | 45 | 38 |
Total Income | 1,561 | 1,487 | 1,587 | 1,446 | 1,435 |
Total Expenditure | 1,367 | 1,272 | 1,347 | 1,450 | 1,323 |
PBIDT | 194 | 215 | 240 | -4 | 112 |
Interest | 103 | 108 | 146 | 150 | 155 |
PBDT | 91 | 107 | 94 | -154 | -43 |
Depreciation | 109 | 108 | 109 | 113 | 110 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 7 | 2 | 5 | 5 | 11 |
Deferred Tax | 1 | 22 | 12 | -9 | 45 |
Reported Profit After Tax | -26 | -25 | -32 | -263 | -209 |
Minority Interest After NP | -14 | -14 | 4 | -11 | 2 |
Net Profit after Minority Interest | -12 | -11 | -36 | -252 | -211 |
Extra-ordinary Items | -89 | 0 | 0 | -52 | -8.88 |
Adjusted Profit After Extra-ordinary item | 77 | -11 | -36 | -200 | -202.12 |
EPS (Unit Curr.) | -0.72 | 0 | -2.42 | 0 | -14.65 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 81 | 81 | 77 | 77 | 72 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 12.76 | 14.68 | 15.5 | -0.28 | 8.01 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | -1.71 | -1.7 | -2.06 | -18.77 | -14.96 |
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
